Xue Jun Su
Director/Miembro de la Junta en SSY GROUP LIMITED .
Fortuna: 15 M $ al 30/04/2024
Perfil
Xue Jun Su is currently an Executive Director at SSY Group Ltd.
and New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
Previously, he worked as Deputy Chairman at Shijiazhuang No.
4 Pharmaceutical Co., Ltd.
and as a Factory Manager at Shijiazhuang No 1 Pharmaceutical Factory.
Mr. Su obtained an undergraduate degree from Hebei Normal University.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
SSY GROUP LIMITED
0.82% | 30/06/2023 | 24 416 000 ( 0.82% ) | 15 M $ | 30/04/2024 |
Cargos activos de Xue Jun Su
Empresas | Cargo | Inicio |
---|---|---|
SSY GROUP LIMITED | Director/Miembro de la Junta | 15/12/2014 |
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Director/Miembro de la Junta | 07/01/2007 |
Antiguos cargos conocidos de Xue Jun Su.
Empresas | Cargo | Fin |
---|---|---|
Shijiazhuang No 1 Pharmaceutical Factory | Corporate Officer/Principal | - |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Presidente | - |
Formación de Xue Jun Su.
Hebei Normal University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
SSY GROUP LIMITED | Health Technology |
Empresas privadas | 3 |
---|---|
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Health Technology |
Shijiazhuang No 1 Pharmaceutical Factory | |
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Finance |
- Bolsa de valores
- Insiders
- Xue Jun Su